{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:31:13Z","timestamp":1774686673617,"version":"3.50.1"},"reference-count":99,"publisher":"Hindawi Limited","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1173,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1111\/j.1742-1241.2012.02924.x","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T07:32:51Z","timestamp":1339745571000},"page":"640-647","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Diabetes mellitus and the heart"],"prefix":"10.1155","volume":"66","author":[{"given":"B. N.","family":"Mercer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. M.","family":"Cubbon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. T.","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,6,15]]},"reference":[{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabet care"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(06)68967-8","article-title":"Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study","volume":"368","author":"Booth","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehl510","article-title":"Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003","volume":"28","author":"Cubbon","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1053\/euhj.2000.2533","article-title":"The prognosis of heart failure in the general population: the Rotterdam Study","volume":"22","author":"Mosterd","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1093\/eurheartj\/ehl363","article-title":"Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart","volume":"27","author":"Lenzen","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB6|cit6","article-title":"Recent US patterns and predictors of prevalent diabetes among acute myocardial infarction patients","volume":"2011","author":"Ovbiagele","year":"2011","journal-title":"Cardiology res prac"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/S0140-6736(02)09089-X","article-title":"Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study","volume":"359","author":"Norhammar","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/hrt.2007.121921","article-title":"Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes","volume":"94","author":"Scholte","year":"2008","journal-title":"Heart"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/diacare.28.3.612","article-title":"The association between glucose abnormalities and heart failure in the population-based Reykjavik study","volume":"28","author":"Thrainsdottir","year":"2005","journal-title":"Diabet care"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(01)05620-3","article-title":"Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study","volume":"358","author":"Davies","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB11|cit11","first-page":"213","article-title":"Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group","volume":"23","author":"Amato","year":"1997","journal-title":"Diabet Met"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.amjmed.2006.05.024","article-title":"Diabetes in heart failure: prevalence and impact on outcome in the population","volume":"119","author":"From","year":"2006","journal-title":"Am J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.107.720847","article-title":"Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people","volume":"117","author":"Schramm","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1161\/hc4901.102568","article-title":"ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guideli","volume":"104","author":"Hunt","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jacc.2011.02.046","article-title":"Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial","volume":"58","author":"Maron","year":"2011","journal-title":"J Am Coll Cardio"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1479164111427752","article-title":"Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era","volume":"9","author":"Kahn","year":"2012","journal-title":"Diab Vasc Dis Res"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1532-429X-12-61","article-title":"Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance","volume":"12","author":"Mather","year":"2010","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1161\/CIRCULATIONAHA.104.517839","article-title":"Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes","volume":"111","author":"Kosiborod","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB20|cit20","article-title":"The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis","author":"Meta-analysis Global Group in Chronic Heart Failure","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/CIRCHEARTFAILURE.108.794008","article-title":"Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland","volume":"1","author":"MacDonald","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: assessment of reduction in mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/euhj.1999.2043","article-title":"Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure","volume":"21","author":"Suskin","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amjcard.2009.09.041","article-title":"Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus","volume":"105","author":"Aguilar","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","article-title":"The incidence of congestive heart failure in type 2 diabetes: an update","volume":"27","author":"Nichols","year":"2004","journal-title":"Diabet care"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.jacc.2009.12.053","article-title":"Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries","volume":"55","author":"Mente","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis - an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2007.06.009","article-title":"Determinants of endothelial function in asymptomatic subjects with and without the metabolic syndrome","volume":"197","author":"Melikian","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0735-1097(98)00211-3","article-title":"Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine","volume":"32","author":"Thorne","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0002-9149(91)90716-X","article-title":"Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study)","volume":"68","author":"Galderisi","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0002-9149(01)01516-8","article-title":"Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study)","volume":"87","author":"Bella","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cardfail.2010.07.249","article-title":"Diabetic cardiomyopathy","volume":"16","author":"Murarka","year":"2010","journal-title":"J Card Fail"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"Boudina","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCULATIONAHA.111.025270","article-title":"Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness","volume":"124","author":"Falc\u00e3o-Pires","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB39|cit39","first-page":"88","article-title":"Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)","volume":"28","author":"Ryd\u00e9n","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00125-007-0898-3","article-title":"Aspirin resistance and diabetes mellitus","volume":"51","author":"Ajjan","year":"2008","journal-title":"Diabetologia"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice","volume":"28","author":"Graham","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","article-title":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevatio","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0002-9149(02)02567-5","article-title":"Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus","volume":"90","author":"Bhatt","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/hc4801.100029","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes","volume":"104","author":"Roffi","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMoa0901316","article-title":"Early versus delayed, provisional eptifibatide in acute coronary syndromes","volume":"360","author":"Giugliano","year":"2009","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/dc08-2064","article-title":"Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions","volume":"32","author":"Angiolillo","year":"2009","journal-title":"Diabet care"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","article-title":"Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial I","volume":"118","author":"Wiviott","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/eurheartj\/ehq325","article-title":"Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"31","author":"James","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(05)67668-4","article-title":"After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes?","volume":"366","author":"Colhoun","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0140-6736(09)60552-3","article-title":"Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials","volume":"373","author":"Hlatky","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2009.10.014","article-title":"Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial","volume":"55","author":"Kapur","year":"2010","journal-title":"J Am Coll Cardi"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"a1331","DOI":"10.1136\/bmj.a1331","article-title":"Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis","volume":"337","author":"Stettler","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(06)69416-6","article-title":"5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study","volume":"368","author":"Lagerqvist","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jacc.2009.11.026","article-title":"5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary","volume":"55","author":"Damman","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archinte.167.13.1353","article-title":"Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the primary coronary angioplasty vs thrombolysis-2 trial","volume":"167","author":"Timmer","year":"2007","journal-title":"Arch Int Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMe1103414","article-title":"Underestimating medical therapy for coronary disease... again","volume":"364","author":"Fang","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1444-2892.2003.00197.x","article-title":"CHART: congestive cardiac failure in hospitals, an Australian review of treatment","volume":"12","author":"Wlodarczyk","year":"2003","journal-title":"Heart Lung Circ"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0002-8703(03)00403-4","article-title":"Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials","volume":"146","author":"Haas","year":"2003","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.109.192065","article-title":"2009 focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0735-1097(03)00262-6","article-title":"Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials","volume":"41","author":"Shekelle","year":"2003","journal-title":"J Am Coll Cardio"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1161\/01.CIR.0000146819.43235.A9","article-title":"Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials","volume":"110","author":"Young","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","author":"Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2010.02.046","article-title":"Cardiovascular events during differing hypertension therapies in patients with diabetes","volume":"56","author":"Weber","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJM200001133420213","article-title":"Spironolactone in heart failure (Author\u2019s reply letter)","volume":"342","author":"Pitt","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cardfail.2011.06.372","article-title":"Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care?","volume":"17","author":"Bertoldi","year":"2011","journal-title":"J Card Fail"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2337\/dc06-2035","article-title":"Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure","volume":"30","author":"Hoppe","year":"2007","journal-title":"Diabet Care"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCHEARTFAILURE.110.959510","article-title":"Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT)","volume":"4","author":"Martin","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"The Lancet"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrcardio.2010.35","article-title":"Intensive glycemic control and cardiovascular disease: an update","volume":"7","author":"Brown","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1161\/CIRCULATIONAHA.109.925883","article-title":"Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial","volume":"121","author":"Goldfine","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archinternmed.2010.207","article-title":"Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality","volume":"170","author":"Nissen","year":"2010","journal-title":"Arch Int Med"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"d1309","DOI":"10.1136\/bmj.d1309","article-title":"Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies","volume":"342","author":"Loke","year":"2011","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1161\/CIR.0b013e3181d34114","article-title":"Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College of Cardiology Foundation","volume":"121","author":"Kaul","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2337\/diacare.28.10.2345","article-title":"Improved clinical outcomes associated with metformin in patients with diabetes and heart failure","volume":"28","author":"Eurich","year":"2005","journal-title":"Diabet care"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/eurheartj\/ehi555","article-title":"Predictors of mortality and morbidity in patients with chronic heart failure","volume":"27","author":"Pocock","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ahj.2011.07.030","article-title":"Intensive glycaemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis","volume":"162","author":"Castagno","year":"2011","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/eurheartj\/ehq162","article-title":"Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options","volume":"31","author":"GDe Caterina","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2012.02924.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2012.02924.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2012.02924.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:03:27Z","timestamp":1643349807000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2012.02924.x"}},"subtitle":["Diabetes mellitus"],"short-title":[],"issued":{"date-parts":[[2012,6,15]]},"references-count":99,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2012.02924.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6,15]]}}}